David Cipolla
About David Cipolla
David Cipolla serves as the Vice President of Research at Insmed Incorporated, where he has worked since 2018. He has a strong background in pharmaceutical research, having previously held significant roles at Genentech and Aradigm Corporation.
Current Role at Insmed
David Cipolla serves as the Vice President of Research at Insmed Incorporated, a position he has held since 2018. He is based in Bridgewater, NJ. In this role, he oversees research initiatives aimed at advancing the company's pipeline of innovative therapies. His leadership focuses on strategic research directions and fostering collaborations that align with Insmed's mission to improve patient outcomes.
Previous Experience at Aradigm Corporation
Prior to his current position, David Cipolla worked at Aradigm Corporation from 2015 to 2018. He served as the Vice President of Preclinical Research and Development. His responsibilities included leading research efforts and managing preclinical projects that contributed to the development of aerosolized therapies. He also held the position of Senior Director of Pharmaceutical Sciences at Aradigm from 1996 to 2015.
Tenure at Genentech
David Cipolla spent eight years at Genentech from 1988 to 1996 as a Senior Research Associate. During his tenure, he contributed to the development and approval of significant therapies, including Pulmozyme® rhDNase for cystic fibrosis, Herceptin® Trastuzumab for breast cancer, and Xolair® Omalizumab for asthma. His work played a crucial role in advancing these important medical treatments.
Educational Background
David Cipolla has an extensive educational background. He earned a Doctor of Philosophy (Ph.D.) from the University of Sydney. He also holds a Master of Science (MS) from the University of California, Davis, and a Bachelor of Science (SB) from the Massachusetts Institute of Technology. His education has provided a strong foundation for his career in pharmaceutical research and development.
Professional Contributions and Leadership
David Cipolla has been actively involved in professional organizations throughout his career. He served on the Board of the International Society of Aerosols in Medicine (ISAM) for two terms from 2011 to 2015. Additionally, he chaired the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) from 2006 to 2008, addressing key scientific and regulatory issues in respiratory product development. He also organized the 2009 ISAM conference and served on the scientific advisory board for subsequent ISAM Congresses.